Clearside Biomedical provides innovative therapies that are delivered to the back of the eye using the suprachoroidal space. They offer XIPERE to treat uveitis macular edema and are developing CLS-AX and CLS-301 for further ocular treatments. The company collaborates with several healthcare organizations and is headquartered in Alpharetta, Georgia.